Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02XSL
|
||||
Former ID |
DIB000235
|
||||
Drug Name |
GlyT1 PET radiotracers
|
||||
Synonyms |
GlyT1 PET radiotracers (schizophrenia); Glycine transporter 1 positron emission tomography radiotracers, Merck; [11C]-CMPyPB; Fluorine-18-CFpyPB; [18F]-MK-6577; GlyT1 PET radiotracers (schizophrenia), Merck & Co; 18F-CFpyPB
|
||||
Indication | Schizophrenia [ICD9: 295; ICD10:F20] | Phase 1 | [532944] | ||
Company |
Merck & Co Inc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
C1CN(CCC1(CNC(=O)c1ccc(cc1Cl)Cl)c1cccc(n1)[18F])S(=O)(=<br />O)CCC
|
||||
Target and Pathway | |||||
Target(s) | Sodium- and chloride-dependent glycine transporter 1 | Target Info | Modulator | [544160] | |
WikiPathways | NRF2 pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.